Serial Number:
87886830
Mark:
EDITAS
Status:
Abandoned-No Statement of Use filed
Status Date:
12-20-2021
Filing Date:
Registration Number:
N/A
Registration Date:
N/A
Pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of cardiovascular, central nervous system, endocrine, gastrointestinal, genetic immunological, infectious, inflammatory, menopausal, metabolic, autoimmune, musculoskeletal, neurological, ophthalmological, psychiatric, respiratory, urogenital, urological, hematologic and viral diseases and disorders; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications for the treatment of erectile dysfunction, sexual dysfunction, cancer, pain and diabetes; pharmaceutical preparations, namely, therapeutic pharmaceuticals developed through genome modifications, namely, antifungal preparations, dermatological preparations, smoking cessation preparations and tissue repair preparations
Mark Description:
N/A
Class:
Pharmaceutical and veterinary preparations
Type of Mark:
Trademark
Published for Opposition Date:
09-18-2018
Owner:
Mark Drawing Status:
Standart Character Mark
Abandon Date:
12-20-2021
Business Name:
WOMBLE BOND DICKINSON (US) LLP
Correspondent Name:
